Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Leishmaniasis Vaccines
Research data from Federal University of Minas Gerais, Institute of Biological Science update understanding of leishmaniasis vaccines
October 1st, 2008
Researchers detail in 'Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology,' new data in leishmaniasis. According to recent research from Belo Horizonte, Brazil, "Cellular immune responses directed against protozoan parasites are key for controlling pathogen replication and disease resolution. However, an uncontrolled, or improperly controlled, response can be deleterious to the host in terms of both allowing for the establishment of pathology, as well as less effective establishment of memory responses." "Human cutaneous leishmaniasis is a disease caused by...
Source: Vaccine Weekly (2008-10-01)
|
